您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [世界银行]:卫生技术评估:澄清误解,加强世界银行对循证优先事项设定的支持(英) - 发现报告

卫生技术评估:澄清误解,加强世界银行对循证优先事项设定的支持(英)

公用事业 2026-01-01 世界银行 徐红金
报告封面

Clarifying misperceptions to enhance World Banksupport to evidence-informed priority-setting Kent Ranson, Carolina Kern, Victoria Fan,andAngela KairuGlobal Health Financing Program KEY MESSAGES •Health technology assessment (HTA) is asystematic, evidence-informed processto prioritize health interventions andoptimize resources under budgetconstraints. •HTA informs sensitive political choices.Its success requires early and continuouscommitment from decision-makers,ensuring recommendations are not onlygenerated but also adopted. •To achieve greater HTA impact,WorldBank projectscan offermore holisticecosystemsupportby leveraging globalnetworks and communities of practicebeyond basic application. •More than just economic evaluation or atool, HTA is a holistic and adaptableapproach, integrating evidence and valuesto support diverse settings, including in low-incomesetting.Public Disclosure Authorized As countries move toward Universal Health Coverage (UHC), the process of deciding on andinvesting in health technologies and interventions becomes increasingly important.A healthtechnology assessment (HTA) can play a role in this process, particularly by informing the design andrevision of a health benefit package. This Knowledge Brief provides an overview of HTA, clarifiescommon misperceptions, and outlines how the World Bank has supported these processes. It alsooffers potential options to support amore holistic response, and ecosystem, among client countriesfor evidence-informed prioritization in health. WHAT IS A HEALTH TECHNOLOGY ASSESSMENT? HTA is a multidisciplinary process that uses explicit methods to determine the value of ahealth technology and, thus, inform decision-makingto promote equitable, efficient, and high-quality health systems (O’Rourke et al. 2020). A health technology can be a drug, vaccine, healthservice, medical device, or medical procedure. HTA has various applications, from helping to developclinical guidelines and essential medicine lists, to supporting the market authorization of newtechnologies and informing pricenegotiations. In low-income settings, defining a health benefitpackage is an essential and well-known application of HTA. HTA and health benefit packages are interconnected: HTA provides the systematic, evidence-informed priority-setting process thatfeeds into, and thus supports, the creation and revision of ahealth benefit package. HTA increases transparency and accountability for significant and broad benefits to healthsystems.HTA makes the reasoning for adopting or rejecting health technologies or services explicitand open to scrutiny. This ensures limited resources are allocated justifiably and in line with publichealth priorities. When HTA is well-integrated into policy processes, it can also build trust amongstakeholders and enhance the legitimacy of decisions about which services to include in a healthbenefit package. Theeffectiveness of HTA hinges on the way the HTA process is set up and structured to ensureit enables a legitimate policy decision. The critical challenge in many countries is that even whenHTA produces a robust recommendation, the decision-making process is not structured to ensurethis recommendation is officially accepted and acted upon. Strong communication of findings andmeaningful stakeholder engagement are certainly important for building trust and understanding,but they are not enough. Finally, the quality and availability of underlying data remain essential;where data are lacking, or where the capacity to interpret data is low, the reliability and relevance ofthe assessments are less robust (Kim et al. 2021). In some contexts, competing processes for prioritization can fragment decision-making andreduce buy-in, particularly those linked to vertical programs. Further, even when HTA is formallyestablished within government structures for informing health funding decisions, there is noguaranteethat its recommendations will be reflected in budget allocations, unless it is by statute ormandatory. COMMON MISPERCEPTIONS ABOUT HEALTH TECHNOLOGY ASSESSMENT This section aims to clarify common misunderstandings and to highlight the true nature andversatility of HTA as a process for prioritizationofinterventions, efficient resource allocation,andbroader health systems strengthening. Misperception 1: HTA is just an economic evaluation HTA is much broader than an economic exercise centered on cost-effectiveness.As shown inFigure 1, HTA has the ability to consider a range of criteria, such as clinical effectiveness, safety,equity, overall fiscal space, and wider social implications. Its goal is to provide objective, evidence-informed information to a variety ofstakeholders, from policymakers to clinicians and patients, toensure decisions are well rounded and comprehensive. Misperception 2: HTA is only for adding new technologies HTA is a versatile tool with wide-ranging applications across a health system.HTA can beused to: •Develop or revise e